XtremisBio, Inc

KRAS Downregulators for KRAS-Driven Cancers

Our Science

We are developing a targeted RAS therapy with a novel mechanism for advanced cancers.

Our site is still under construction. Thank you for your patience.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept